LAS VEGAS– Kerecis, a leader in tissue regeneration using sustainably sourced fish skin, will highlight its intact fish-skin graft technology at the Symposium on Advanced Wound Care (SAWC Fall) 2025, taking place September 3–6 at Caesars Forum in Las Vegas. The company will host an educational symposium, cultural event, interactive sessions, and exhibit at booth 501.
Kerecis will showcase its Shield and MariGen wound and tissue repair products alongside new data from the Odinn Trial, a randomized controlled study of 255 patients across 15 centers and four countries. The trial focused on diabetic foot ulcers with exposed bone or tendon (University of Texas grades 2 and 3) and found that wounds treated with Kerecis fish-skin grafts achieved 66% higher relative healing rates at 16 weeks compared with standard of care.
Visitors will also experience Kerecis’ new volcano-themed booth, inspired by Icelandic nature and designed to symbolize the regenerative potential of lava—mirroring the healing properties of the company’s intact fish-skin technology.
“Our mission is to provide clinicians with solutions that combine clinical effectiveness with sustainability,” said Fertram Sigurjonsson, Founder and CEO of Kerecis and Executive Vice President of Wound and Tissue Repair at Coloplast. “We’re excited to translate years of bench research into sessions that demonstrate how our intact fish-skin grafts are redefining tissue regeneration pathways for complex wounds.”
